Biotech R&D Startup Benchling Hits $4 Billion Valuation As The Company Starts Laying Groundwork For An IPO Sajith Wickramasekara was just 24 when he made the Forbes 30 Under 30 list for his biotech R&D startup, Benchling. Now his company is worth $4 billion with a new $200 million round led by Sequoia.